Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents
出版年份 2021 全文链接
标题
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents
作者
关键词
Osteoporosis, Postmenopausal, Bone, Anti-resorptive, Anabolic, Combination, Sequential
出版物
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
Volume 50, Issue 2, Pages 179-191
出版商
Elsevier BV
发表日期
2021-05-20
DOI
10.1016/j.ecl.2021.03.010
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Which Drug Next? Sequential Therapy for Osteoporosis
- (2020) Barbara P Lukert JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized Trial
- (2020) Andrew Grey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hormone Therapy for Postmenopausal Women
- (2020) JoAnn V. Pinkerton NEW ENGLAND JOURNAL OF MEDICINE
- Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism
- (2020) Megan M. Weivoda et al. Nature Communications
- T ‐Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial
- (2020) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treatment with zoledronate subsequent to denosumab in osteoporosis: a randomized trial
- (2020) Anne Sophie Sølling et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture
- (2020) Kenneth G. Saag et al. CLINICAL THERAPEUTICS
- Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches
- (2020) Bente Langdahl BONE
- Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use
- (2019) Houchen Lyu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial
- (2019) John P. Bilezikian et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effects of Zoledronate on Cancer, Cardiac Events, and Mortality in Osteopenic Older Women
- (2019) Ian R Reid et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone Mineral Density After Transitioning From Denosumab to Alendronate
- (2019) David Kendler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Abaloparatide Versus Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
- (2019) Benjamin Z Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial
- (2019) Joy N Tsai et al. Lancet Diabetes & Endocrinology
- ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
- (2018) Henry G Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Phase 3 Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
- (2018) E Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis
- (2018) David W Dempster et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Teriparatide vs risedronate for osteoporosis
- (2018) Yair Liel LANCET
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Fracture Prevention with Zoledronate in Older Women with Osteopenia
- (2018) Ian R. Reid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis
- (2017) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- Romosozumab Treatment in Postmenopausal Osteoporosis
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Osteoporosis Therapy in Postmenopausal Women With High Risk of Fracture
- (2016) Anne R. Cappola et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Pathophysiology and Treatment of Osteoporosis
- (2015) Matthew T. Drake et al. CLINICAL THERAPEUTICS
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
- (2014) Aliya A Khan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab and bisphosphonates: Different mechanisms of action and effects
- (2010) Roland Baron et al. BONE
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
- (2010) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice
- (2009) Matthew T. Drake et al. MAYO CLINIC PROCEEDINGS
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effective osteoporosis treatment thresholds: the United States perspective
- (2008) A. N. A. Tosteson et al. OSTEOPOROSIS INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation